Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 4,701–4,725 of 7,816 matching trials · page 189 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Alzheimer's Disease Long-term Follow-up Study (ALF Study) NCT00165724 Donepezil Hydrochloride Runs in: South Korea · 7 sites |
PHASE4 symptomatic-cholinergic |
COMPLETED | 114 | Eisai Korea Inc. INDUSTRY |
2021-12-30 |
|
Non Verbal Communication and Dementia NCT04255329 Montessori reading roundtable; Usual reading Runs in: France · 1 site |
NA other |
WITHDRAWN | 0 | University Hospital, Montpellier OTHER |
2021-12-30 |
|
In Vivo Alzheimer Proteomics NCT02263235 administration of stable isotope-labelled leucine-; collection of C... Runs in: France · 1 site |
NA other |
TERMINATED | 89 | University Hospital, Montpellier OTHER |
2021-12-28 |
|
Use of Saliva for Alzheimer's Disease Diagnosis NCT02864303 Saliva samples Runs in: France · 1 site |
NA other |
TERMINATED | 88 | University Hospital, Montpellier OTHER |
2021-12-28 |
|
BCG and Plasma Amyloid in Non-Demented Adults NCT04449926 Bacillus of Calmette and Guerin (BCG) Runs in: United States · 1 site |
PHASE2 other |
COMPLETED | 49 | Mindful Diagnostics and Therapeutics, LLC INDUSTRY |
2021-12-23 |
|
Impact of the Olfactory Stimulation on the People With Mild Dementia Via the Horticultural Therapy NCT05168098 board game comparison; olfactory stimulation intervention Runs in: Taiwan · 1 site |
NA other |
COMPLETED | 28 | National Taiwan Normal University OTHER |
2021-12-23 |
|
Screening for Systemic Amyloidosis Via the Ligamentum Flavum NCT03923920 Biopsy Runs in: United States · 1 site |
NA other |
COMPLETED | 200 | The Cleveland Clinic OTHER |
2021-12-22 |
|
Midazolam Effect on Agitation Postnasal Surgery NCT05165914 Intravenous midazolam before emergence from general anesthesia; Int... Runs in: Jordan · 1 site |
NA other |
COMPLETED | 100 | Jordanian Royal Medical Services OTHER |
2021-12-21 |
|
The Effectiveness of De-escalation in Management of Aggression NCT05166278 De-escalation training Runs in: Slovenia · 6 sites |
NA other |
COMPLETED | 6 | University Medical Centre Maribor OTHER |
2021-12-21 |
|
Application of Transcranial Alternating Current Stimulation for Modulation of Sleep and Cognitive Performance NCT03112902 Application of Transcranial Alternating Current Stimulation for Mod... Runs in: United States · 1 site |
NA other |
TERMINATED | 24 | University of Colorado, Denver OTHER |
2021-12-17 |
|
Trial of Rifaximin in Probable Alzheimer's Disease NCT03856359 Rifaximin 550 milligrams (MG) Runs in: United States · 1 site |
PHASE2 other |
COMPLETED | 10 | Duke University OTHER |
2021-12-17 |
|
Feasibility of Passive Data Collection in Dementia Subjects With Agitation NCT04413851 Runs in: United States · 2 sites |
NA other |
COMPLETED | 1 | HealthMode Inc. INDUSTRY |
2021-12-17 |
|
Low Dose RT to Reduce Cerebral Amyloidosis in Early Alzheimer's NCT02769000 10 GY in 5 daily fractions; 20 GY in 10 daily fractions Runs in: United States · 1 site |
NA other |
TERMINATED | 5 | Virginia Commonwealth University OTHER |
2021-12-16 |
|
Lomecel-B Infusion Versus Placebo in Patients With Alzheimer's Disease NCT02600130 Longeveron Mesenchymal Stem Cells; Placebo Runs in: United States · 3 sites |
PHASE1 other |
COMPLETED | 33 | Longeveron Inc. INDUSTRY |
2021-12-14 |
|
Nociception-Level (NOL) for the Assessment of Pain in Patient Unable to Self-Report NCT04581642 PMD200 Runs in: Israel · 1 site |
NA other |
COMPLETED | 33 | Medasense Biometrics Ltd OTHER |
2021-12-14 |
|
Deprescribing Intervention Among Nursing Home Residents With Major Neurocognitive Disorders NCT05155748 Continuous education and knowledge exchange Runs in: Canada · 1 site |
NA other |
COMPLETED | 100 | Dre Edeltraut Kröger OTHER |
2021-12-14 |
|
A Study of Gantenerumab in Participants With Prodromal Alzheimer's Disease NCT01224106 Gantenerumab; Placebo Runs in: Argentina; Australia; Belgium; Brazil; Canada; Chile; Cze... · 139 sites |
PHASE3 anti-amyloid-antibody |
COMPLETED | 799 | Hoffmann-La Roche INDUSTRY |
2021-12-13 |
|
Clinical Study of TripleA for Treatment of Alcohol Addiction in Outpatient Care NCT03195894 TripleA |
NA other |
COMPLETED | 115 | Kontigo Care AB INDUSTRY |
2021-12-13 |
|
Ginkgo Leaf Extract and Armillariella Mellea Powder Oral Solution for the Treatment of Motoric Cognitive Risk Syndrome NCT04492241 Ginkgo Leaf Extract and Armillariella Mellea Powder Oral Solution; ... Runs in: China · 1 site |
NA other |
UNKNOWN | 800 | Beijing Tiantan Hospital OTHER |
2021-12-09 |
|
Neurotoxicity and Cardiotoxicity in Total Joint Arthroplasty NCT04166539 Questionnaires; Interviews; Blood draw; Magnetic Resonance Imaging;... Runs in: United States · 1 site |
NA other |
COMPLETED | 115 | Mayo Clinic OTHER |
2021-12-08 |
|
Amyloid-beta PET Imaging With 18F-92 in Alzheimer's Disease NCT04926272 18F-92 Runs in: China · 1 site |
PHASE2 other |
UNKNOWN | 50 | First Affiliated Hospital of Fujian Medical University OTHER |
2021-12-06 |
|
Taxonomy of Neurodegenerative Diseases : Observational Study in Alzheimer's Disease and Parkinson's Disease NCT05040048 Clinical, biological and imaging assessment Runs in: France; Germany; Spain; Sweden · 4 sites |
NA other |
COMPLETED | 220 | Institut National de la Santé Et de la Recherche Médicale, France OTHER_GOV |
2021-12-03 |
|
Evaluating the Efficacy and Safety of Nilotinib BE in Subjects With Early Alzheimer's Disease NCT05143528 Nilotinib BE 84mg; Nilotinib BE 112 mg; Placebo |
PHASE3 other |
UNKNOWN | 1,275 | KeifeRx, LLC INDUSTRY |
2021-12-03 |
|
Electronic Consultation for AD/ADRD Residents Experiencing Infectious Diseases NCT04812769 eCARE-ID; Standard of Care |
NA other |
WITHDRAWN | 0 | Yale University OTHER |
2021-12-01 |
|
A Study of Brain Aging in Vietnam War Veterans NCT01687153 Runs in: United States · 19 sites |
NA other |
COMPLETED | 289 | University of Southern California OTHER |
2021-11-29 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial